from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3245c/mtrB

LFCtreatmentdescriptionclass of inhibitor

-0.857

Amikacinug/mL Amikacintranslation

-0.736

Cap5-10ug/mL Capreomycintranslation

-0.849

Rox10-50 ug/mL Roxithromycintranslation

-0.088

SM2-5 ug/mL Streptomycintranslation

-0.020

Tet5-10 ug/mL Tetracyclinetranslation

-0.520

Rif0.2-5ug/mL Rifampicintranscription

0.093

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.610

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.877

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.210

CPZ10-50 ug/mL Chlorpromazinerespiration

0.692

Clofazimine10-13 ug/mL Clofaziminerespiration

0.063

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.614

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.257

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.699

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.082

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.345

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.092

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.097

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.600

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.898

KCN5-20 ug/mL Potassium cyaniderespiration

-0.355

NaN30.2-2 mM Sodium aziderespiration

0.459

Nigericin50 uM Nigericinrespiration

0.939

TRC10-150 ug/mL Triclosanrespiration

0.095

TRZ10-25 ug/mL Thioridazinerespiration

-1.946

Valinomycin0.5-10 uM Valinomycinrespiration

-2.867

ZnSO42 mM ZnSO4respiration

-0.983

menadione6-10 ug/mL Menadionerespiration

-0.068

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.178

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.181

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.556

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.524

NRP_1Non-replicating persistence stage 1dosRassociated

0.214

Amp0.2mg/mL AmpicillincellWall

0.143

Cephalexin20-100 ug/mL CephalexincellWall

-0.338

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.135

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.192

EMB10-20 ug/mL EthambutolcellWall

-0.119

Eta12-40 ug/mL EthionamidecellWall

0.104

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.509

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.533

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.308

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.686

BZA0.12 mg/mL BenzamidearomaticAmides

0.307

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.213

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.773

H2O24 mM hydrogen peroxideDNAdamaging

-0.343

Levo10 ug/mL LevofloxacinDNAdamaging

-0.383

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.308

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.003

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.025

UVUV-irradiationDNAdamaging

0.576

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.646

Antimycin12.5-50 ug/mL Antimycin A?

-0.051

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.241

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.546

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.403

PA8240.2-2 ug/mL PA-824?

1.350

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.126

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.585

Verapamil50 uM Verapamil?

-0.530

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.031

methoxatin10-20 ug/mL Methoxatin?